Paper - WANFANG MED ONLINE

You Position: Home > Paper

Mechanisms responsible for pulmonary hypertension

( views:99, downloads:4 )

Author:: No author available

Journal Title:: CHINESE MEDICAL JOURNAL

Issue:: 24

DOI:: No doi available

Key Word:: hypertension,pulmonary;endothelial cells;myocytes,smooth muscle;extracellular matrix;hydrogen sulfide

Abstract： @@ Pulmonary hypertension is a pathophysiologic process characterized by progressive elevation of pulmonary vascular resistance and right heart failure, which is a common complication of many diseases. Pulmonary hypertension with no apparent causes (unknown etiology) is termed primary pulmonary hypertension or, more recently, idiopathic pulmonary arterial hypertension (IPAH).

Reference

[1]LI Fu-hai,XIA Wei,LI Ai-wu,etc.Inhibition of rho kinase attenuates high flow induced pulmonary hypertension in rats[J].2007,(1).
[2]魏冰,杜军保,张春雨,等.高肺血流量对大鼠肺动脉压及肺动脉平滑肌细胞增殖与凋亡的影响[J].2002,(1).
[3]金红芳,杜淑旭,赵霞,等.内源性二氧化硫对心血管系统的调节意义[J].2007,(4).
[4]WANG Yan-fei,Mainali prabha,TANG Chao-shu,etc.Effects of nitric oxide and hydrogen sulfide on the relaxation of pulmonary arteries in rats[J].2008,(5).
[5]齐建光,杜军保,汪立,等.L-精氨酸对低氧性肺血管结构重建的干预研究[J].2001,(9).
[6]张春雨,杜军保,卜定方,等.内源性硫化氢在大鼠低氧性肺动脉高压中的作用[J].2003,(5).
[7]齐建光,汤秀英,杜军保,等.高肺血流量对大鼠肺腺泡内动脉超微结构的影响[J].2002,(4).
[8]杜军保,陈晓波,耿彬,等.硫化氢作为心血管信号分子的研究[J].2002,(2).
[9]杜淑旭,杜军保,唐朝枢.内源性二氧化硫及其衍生物的生理作用研究进展[J].2006,(3).
[10]杜淑旭,张春雨,金红芳,等.二氧化硫衍生物舒张大鼠离体主动脉血管环的效应及其机制研究[J].2006,(6).
[11]Yutani C,Matsuo H,Ohe T,etc.Chronic infusion of adrenomedullin reduces pulmonary hypertension and lessens right ventricular hypertrophy in rats administered monocrotaline.[J].1998,355(1).
[12]R M, Tuder,C D, Cool,M W, Geraci,etc.Prostacyclin synthase expression is decreased in lungs from patients with severe pulmonary hypertension.[J].1999,159.
[13]Girerd B,Yaici A,Humbert M,etc.Genes and pulmonary arterial hypertension.[J].2007,74(2).
[14]J X, Yuan,A M, Aldinger,M, Juhaszova,etc.Dysfunctional voltage-gated K+ channels in pulmonary artery smooth muscle cells of patients with primary pulmonary hypertension.[J].1998,98.
[15]Lane KB.,Pauciulo MW.,Thomson JR.,etc.Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension[J].2000,26(1).
[16]Tang C,Tang X,Wei B,etc.The upregulation of endothelial nitric oxide synthase and urotensin-II is associated with pulmonary hypertension and vascular diseases in rats produced by aortocaval shunting.[J].2004,19(2).
[17]Huang W,Fung YC,Yuan JX,etc.Cellular and molecular mechanisms of pulmonary vascular remodeling: role in the development of pulmonary hypertension.[J].2004,68(2).
[18]Cheever KH.An overview of pulmonary arterial hypertension: risks, pathogenesis, clinical manifestations, and management.[J].2005,20(2).
[19]Rubin LJ,Galie N,Simonneau G,etc.Bosentan therapy for pulmonary arterial hypertension.[J].2002,346(12).
[20]Raffestin B,Eddahibi S,Adnot S,etc.Attenuated hypoxic pulmonary hypertension in mice lacking the 5-hydroxytryptamine transporter gene (see comments)[J].2000,105(11).
[21]Chaoshu T,Junbao D,Hui Y,etc.Effect of L-arginine on collagen of high flow-induced pulmonary arterial remodeling.[J].2005,69(5).
[22]Shroyer KR,Voelkel NF,Markham NE,etc.Monoclonal endothelial cell proliferation is present in primary but not secondary pulmonary hypertension.[J].1998,101(5).
[23]Levy, H.,Abenhaim, L.,Moride, Y.,etc.Appetite-suppressant drugs and the risk of primary pulmonary hypertension[J].1997,12(1).
[24]John H, Newman,Barry L, Fanburg,Stephen L, Archer,etc.Pulmonary arterial hypertension: future directions: report of a National Heart, Lung and Blood Institute/Office of Rare Diseases workshop.[J].2004,109(24).
[25]Z, Nong,J M, Stassen,L, Moons,etc.Inhibition of tissue angiotensin-converting enzyme with quinapril reduces hypoxic pulmonary hypertension and pulmonary vascular remodeling.[J].1996,94.
[26]R J, Barst,L J, Rubin,W A, Long,etc.A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension.[J].1996,334(5).
[27]Foletta VC,Soosairaiah J,Lim MA,etc.Direct signaling by the BMP type II receptor via the cytoskeletal regulator LIMK1.[J].2003,162(6).
[28]Tang CS,Ding YG,Du JB,etc.Chronic administration of adrenomedullin attenuates hypoxic pulmonary vascular structural remodeling and inhibits proadrenomedullin N-terminal 20-peptide production in rats.[J].2007,28(4).
[29]J H, Morse,A C, Jones,R J, Barst,etc.Mapping of familial primary pulmonary hypertension locus (PPH1) to chromosome 2q31-q32.[J].1997,95.